194 related articles for article (PubMed ID: 7687634)
1. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.
Haziot A; Rong GW; Silver J; Goyert SM
J Immunol; 1993 Aug; 151(3):1500-7. PubMed ID: 7687634
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
Golenbock DT; Bach RR; Lichenstein H; Juan TS; Tadavarthy A; Moldow CF
J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
[TBL] [Abstract][Full Text] [Related]
3. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS
J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028
[TBL] [Abstract][Full Text] [Related]
4. Direct effects of endotoxin on the endothelium: barrier function and injury.
Bannerman DD; Goldblum SE
Lab Invest; 1999 Oct; 79(10):1181-99. PubMed ID: 10532583
[TBL] [Abstract][Full Text] [Related]
5. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood.
Haziot A; Rong GW; Bazil V; Silver J; Goyert SM
J Immunol; 1994 Jun; 152(12):5868-76. PubMed ID: 7515917
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
Hailman E; Lichenstein HS; Wurfel MM; Miller DS; Johnson DA; Kelley M; Busse LA; Zukowski MM; Wright SD
J Exp Med; 1994 Jan; 179(1):269-77. PubMed ID: 7505800
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
[TBL] [Abstract][Full Text] [Related]
8. LPS, recIL1 and smooth muscle cell-IL1 activate vascular cells by specific mechanisms.
Loppnow H
Prog Clin Biol Res; 1994; 388():309-21. PubMed ID: 7530369
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
Leeuwenberg JF; Dentener MA; Buurman WA
J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro.
Goldblum SE; Brann TW; Ding X; Pugin J; Tobias PS
J Clin Invest; 1994 Feb; 93(2):692-702. PubMed ID: 7509346
[TBL] [Abstract][Full Text] [Related]
11. LPS binding protein and CD14 in the LPS dependent activation of cells.
Tobias PS; Gegner J; Han J; Kirkland T; Kravchenko V; Leturcq D; Lee JD; Moriarty A; Mathison JC; Pugin J
Prog Clin Biol Res; 1994; 388():31-9. PubMed ID: 7530370
[No Abstract] [Full Text] [Related]
12. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
Grunwald U; Krüger C; Schütt C
Circ Shock; 1993 Mar; 39(3):220-5. PubMed ID: 7680967
[TBL] [Abstract][Full Text] [Related]
13. Interaction between CD14 lipopolysaccharide binding protein and bactericidal/permeability-increasing protein during lipopolysaccharide-induced cell activation.
Dentener MA; Von Asmuth EJ; Francot GJ; Buurman WA
Prog Clin Biol Res; 1994; 388():59-70. PubMed ID: 7530372
[No Abstract] [Full Text] [Related]
14. Cross-linking of CD14 molecules on monocytes results in a CD11/CD18- and ICAM-1-dependent adherence to cytokine-stimulated human endothelial cells.
Beekhuizen H; Blokland I; van Furth R
J Immunol; 1993 Feb; 150(3):950-9. PubMed ID: 7678628
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.
Haziot A; Tsuberi BZ; Goyert SM
J Immunol; 1993 Jun; 150(12):5556-65. PubMed ID: 7685797
[TBL] [Abstract][Full Text] [Related]
16. Binding of lipopolysaccharide (LPS) to CHO cells does not correlate with LPS-induced NF-kappaB activation.
Hamann L; Schumann RR; Flad HD; Brade L; Rietschel ET; Ulmer AJ
Eur J Immunol; 2000 Jan; 30(1):211-6. PubMed ID: 10602043
[TBL] [Abstract][Full Text] [Related]
17. Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD14.
Pugin J; Ulevitch RJ; Tobias PS
Prog Clin Biol Res; 1995; 392():369-73. PubMed ID: 8524944
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.
Pugin J; Schürer-Maly CC; Leturcq D; Moriarty A; Ulevitch RJ; Tobias PS
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2744-8. PubMed ID: 7681988
[TBL] [Abstract][Full Text] [Related]
19. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria.
Jack RS; Grunwald U; Stelter F; Workalemahu G; Schütt C
Eur J Immunol; 1995 May; 25(5):1436-41. PubMed ID: 7539760
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of substitution of amino acids 9-13 and 91-101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide.
Stelter F; Loppnow H; Menzel R; Grunwald U; Bernheiden M; Jack RS; Ulmer AJ; Schütt C
J Immunol; 1999 Dec; 163(11):6035-44. PubMed ID: 10570291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
